2-165747998-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_004482.4(GALNT3):​c.*783A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00856 in 177,222 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0097 ( 23 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 1 hom. )

Consequence

GALNT3
NM_004482.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.29

Publications

0 publications found
Variant links:
Genes affected
GALNT3 (HGNC:4125): (polypeptide N-acetylgalactosaminyltransferase 3) This gene encodes UDP-GalNAc transferase 3, a member of the GalNAc-transferases family. This family transfers an N-acetyl galactosamine to the hydroxyl group of a serine or threonine residue in the first step of O-linked oligosaccharide biosynthesis. Individual GalNAc-transferases have distinct activities and initiation of O-glycosylation is regulated by a repertoire of GalNAc-transferases. The protein encoded by this gene is highly homologous to other family members, however the enzymes have different substrate specificities. [provided by RefSeq, Jul 2008]
GALNT3 Gene-Disease associations (from GenCC):
  • tumoral calcinosis, hyperphosphatemic, familial, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • tumoral calcinosis, hyperphosphatemic, familial, 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 2-165747998-T-C is Benign according to our data. Variant chr2-165747998-T-C is described in ClinVar as [Benign]. Clinvar id is 331773.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00971 (1477/152140) while in subpopulation AFR AF = 0.0339 (1406/41532). AF 95% confidence interval is 0.0324. There are 23 homozygotes in GnomAd4. There are 692 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALNT3NM_004482.4 linkc.*783A>G 3_prime_UTR_variant Exon 11 of 11 ENST00000392701.8 NP_004473.2 Q14435-1
GALNT3XM_005246449.2 linkc.*783A>G 3_prime_UTR_variant Exon 11 of 11 XP_005246506.1 Q14435-1
GALNT3XM_011510929.2 linkc.*783A>G 3_prime_UTR_variant Exon 11 of 11 XP_011509231.1 Q14435-1
GALNT3XM_017003770.2 linkc.*783A>G 3_prime_UTR_variant Exon 11 of 11 XP_016859259.1 Q14435-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALNT3ENST00000392701.8 linkc.*783A>G 3_prime_UTR_variant Exon 11 of 11 1 NM_004482.4 ENSP00000376465.3 Q14435-1
GALNT3ENST00000409882.5 linkc.*783A>G 3_prime_UTR_variant Exon 8 of 8 1 ENSP00000386955.1 E7EUL0
ENSG00000307262ENST00000824811.1 linkn.130+1075T>C intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.00960
AC:
1459
AN:
152022
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0335
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00380
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00480
GnomAD4 exome
AF:
0.00159
AC:
40
AN:
25082
Hom.:
1
Cov.:
0
AF XY:
0.00122
AC XY:
14
AN XY:
11480
show subpopulations
African (AFR)
AF:
0.0378
AC:
32
AN:
846
American (AMR)
AF:
0.00174
AC:
1
AN:
574
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1478
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5512
South Asian (SAS)
AF:
0.00
AC:
0
AN:
206
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
12
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
148
European-Non Finnish (NFE)
AF:
0.0000702
AC:
1
AN:
14238
Other (OTH)
AF:
0.00290
AC:
6
AN:
2068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00971
AC:
1477
AN:
152140
Hom.:
23
Cov.:
32
AF XY:
0.00930
AC XY:
692
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0339
AC:
1406
AN:
41532
American (AMR)
AF:
0.00380
AC:
58
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67970
Other (OTH)
AF:
0.00475
AC:
10
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
69
139
208
278
347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00327
Hom.:
3
Bravo
AF:
0.0111

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Tumoral calcinosis, hyperphosphatemic, familial, 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
8.8
DANN
Benign
0.85
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115493554; hg19: chr2-166604508; API